Simplex Trading
NDRM

Simplex Trading’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Simplex Trading’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,928
Closed -$308K – 7382
2017
Q3 		$308K Buy
+7,928
New +$292K 0.01% 943
2016
Q3 		– Sell
-3,350
Closed -$54K – 7165
2016
Q2 		$54K Buy
3,350
+1,741
+108% +$29.3K ﹤0.01% 1991
2016
Q1 		$22K Buy
+1,609
New +$21.7K ﹤0.01% 2746

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Simplex Trading's NDRM Position: Q4 2017 in Review

Simplex Trading sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 7,928 shares — an estimated $308K sold.

Simplex Trading first reported a position in NDRM in Q1 2016 and held it in 3 quarters. The position peaked at $308K in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Simplex Trading reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Simplex Trading sold 7,928 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $308K.
  • Simplex Trading first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2016 and held it in 3 quarters.
  • Simplex Trading's NeuroDerm Ltd. Ordinary Shares position peaked at $308K in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.